Title of article
Relation of Positive T Wave in Lead aVR to Risk of Cardiovascular Mortality
Author/Authors
Anttila، نويسنده , , Ismo and Nikus، نويسنده , , Kjell and Nieminen، نويسنده , , Tuomo and Jula، نويسنده , , Antti and Salomaa، نويسنده , , Veikko and Reunanen، نويسنده , , Antti and Nieminen، نويسنده , , Markku Sakari and Lehtimنki، نويسنده , , Terho and Virtanen، نويسنده , , Vesa and Kنhِnen، نويسنده , , Mika، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2011
Pages
6
From page
1735
To page
1740
Abstract
We examined the prevalence and prognostic impact of a positive T wave in lead aVR (aVRT+) on a standard electrocardiogram in the general population. Data were collected from a large nationally representative (random sample) health examination survey conducted in Finland from 2000 through 2001. The survey consisted of 6,354 subjects (2,876 men and 3,478 women) ≥30 years who participated in the field health examination including standard electrocardiographic (ECG) recording at rest. The prevalence of aVRT+ (defined as positive or isoelectric T wave in lead aVR) was 2.2%. During the median follow-up of 98.5 months (interquartile range 96.6 to 99.6), there were 214 (3.5%) cardiovascular (CV) deaths. In Cox regression analysis after adjustment for age and gender, relative risks for CV and total mortalities associated with aVRT+ were 3.24 (95% confidence interval [CI] 2.32 to 4.54, p <0.001) and 1.91 (95% CI 1.47 to 2.49, p <0.001), respectively. In the fully adjusted model controlling for other risk factors, CV morbidity, and ECG findings, the relative risk for CV mortality for aVRT+ was 2.94 (95% CI 2.07 to 4.18, p <0.001). In conclusion, aVRT+, an easily recognized ECG finding, predicts risk for CV mortality in the general population. This finding could aid in screening for risk of total and CV mortalities.
Journal title
American Journal of Cardiology
Serial Year
2011
Journal title
American Journal of Cardiology
Record number
1901652
Link To Document